Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Damora Therapeutics granted inducement stock options to nine newly hired non-executive employees on July 1, 2026, under Nasdaq Listing Rule 5635(c)(4). The awards cover an aggregate of 453,500 shares of common stock with a 10-year term and an exercise price of $26.01 per share.
Key figures
- Grantee count
- 9
- Exercise price
- 26.01
- Shares granted
- 453500
- Option term years
- 10
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.